icon-folder.gif   Conference Reports for NATAP  
 
  IDWeek
October 3 -7, 2018
San Francisco, CA
Back grey_arrow_rt.gif
 
 
 
Time to Viral Suppression Does not Impact SVR in Patients Treated With Glecaprevir/Pibrentasvir
 
 
  Reported by Jules Levin
Infectious Diseases Society of America, October 3-7, 2018, San Francisco, California
 
Christoph Sarrazin1, Jordan J Feld2, Douglas E Dylla3, Sanjeev Arora4, David Victor III5, Yiran B Hu3, Stanley Wang3, Federico J Mensa3, David Wyles6 1JW Goethe University Hospital, Frankfurt, Germany and St. Josefs-Hospital, Wiesbaden, Germany; 2Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada; 3AbbVie Inc., North Chicago, Illinois, United States; 4University of New Mexico, Albuquerque, New Mexico, United States; 5Houston Methodist Hospital, Houston, Texas, United States; 6Denver Health Medical Center, Denver, Colorado, United States

1011181

1011182

1011183

1011184

1011185

1011186

1011187

1011188

1011189

10111810

10111811

10111812